About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021 04-12-2021 at 4:05 PM EDT Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen 03-17-2021 at 4:05 PM EDT Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection 03-05-2021 at 6:45 PM EST VIEW ALL NEWS Upcoming Events & Presentations Adaptive Biotechnologies First Quarter Financial Results May 5, 2021 at 4:30 PM EDT Add to Outlook Add to Google Calendar Listen to webcast Past Events & Presentations Cowen 41st Annual Health Care Conference Mar 2, 2021 at 10:30 AM EST Listen to webcast Adaptive Biotechnologies Fourth Quarter Financial Results Feb 24, 2021 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Fourth Quarter and FY 2020 Earning Conference Call 1.3 MB 39th Annual J.P. Morgan Healthcare Conference Jan 11, 2021 at 4:30 PM EST Listen to webcast View Presentation 2.8 MB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Apr 15, 2021 12:10 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
